ALLMedicine™ Living Donor Hepatectomy Center
Research & Reviews 99 results
https://clinicaltrials.gov/ct2/show/NCT05255510
May 12th, 2022 - Operative blood loss and need for transfusion are risk factors associated with mortality after partial hepatectomy. The low central venous pressure (CVP) anesthetic technique has been strongly advocated to minimize hepatic venous bleeding during h...
https://doi.org/10.1111/ctr.14703
Clinical Transplantation; Cheah YL, Heimbach J et. al.
May 11th, 2022 - There are currently no guidelines pertaining to ERAS pathways in living donor hepatectomy. To identify whether surgical technique influences immediate and short-term outcomes after living liver donation surgery DATA SOURCES: : Ovid MEDLINE, Embase...
https://doi.org/10.1111/ctr.14688
Clinical Transplantation; Ruffolo LI, Levstik M et. al.
Apr 26th, 2022 - Deep venous thrombosis (DVT) prophylaxis is often employed to prevent the potentially serious complication of pulmonary embolism (PE). However, little data exist regarding the optimal DVT prophylaxis strategy for living donors undergoing hepatecto...
https://clinicaltrials.gov/ct2/show/NCT04767503
Mar 23rd, 2022 - Hepatectomies are performed for the treatment of hepatic tumors and livingdonor liver transplantation. The success of liver resection relies on the remnant liver's ability to regenerate after major tissue loss. Despite appropriate liver remnant vo...
https://doi.org/10.1111/ctr.14649
Clinical Transplantation; Hogan BJ, Pai SL et. al.
Mar 18th, 2022 - The optimal analgesic strategy for patients undergoing donor hepatectomy is not known and the potential short- and long-term physical and psychological consequences of complications are significant. To identify whether a multimodal approach to pai...
Clinicaltrials.gov 13 results
https://clinicaltrials.gov/ct2/show/NCT05255510
May 12th, 2022 - Operative blood loss and need for transfusion are risk factors associated with mortality after partial hepatectomy. The low central venous pressure (CVP) anesthetic technique has been strongly advocated to minimize hepatic venous bleeding during h...
https://clinicaltrials.gov/ct2/show/NCT04767503
Mar 23rd, 2022 - Hepatectomies are performed for the treatment of hepatic tumors and livingdonor liver transplantation. The success of liver resection relies on the remnant liver's ability to regenerate after major tissue loss. Despite appropriate liver remnant vo...
https://clinicaltrials.gov/ct2/show/NCT04422925
Jan 11th, 2022 - The postoperative delirium picture is a serious and common complication seen after any major surgery, including hepatic resection. Delirium is an acute state of confusion characterized by impaired consciousness, reduced ability to focus on attenti...
https://clinicaltrials.gov/ct2/show/NCT04079673
Oct 21st, 2021 - As the only curative treatment for end-stage liver diseases, liver transplantation has been widely carried out around the world. The shortage of organs from deceased donors facilitate the adoption of living donor liver transplantation. Living dono...
https://clinicaltrials.gov/ct2/show/NCT03865264
Aug 28th, 2020 - Donor safety and outcomes are the chief concerns of programs performing living donor liver and kidney transplantation. The protection of donors from physical and emotional harm has been a fundamental principle in living donor liver and kidney dona...